Emeset (4mg/8mg) Tablets (Ondansetron) – Zofran | Used to Prevent Nausea and Vomiting Caused by Chemotherapy, Surgery, Radiotherapy.
Buy Emeset 4mg (Ondansetron), Emeset Tablet is used for preventing nausea and vomiting caused by chemotherapy (in adults or children) or radiotherapy for cancer or after surgery in adults. Ondansetron belongs to a class of drugs known as anti-emetics which inhibit serotonin. It works on small intestine and the part of the brain that controls vomiting or nausea.
Product Overview
Emeset Tablet is an antiemetic medication containing Ondansetron used to prevent and treat nausea and vomiting caused by cancer chemotherapy, radiation therapy, and post-operative surgical procedures. By blocking the action of serotonin—a natural substance in the body that can trigger nausea and vomiting—Emeset provides targeted relief, helping patients maintain comfort and adhere to their treatment plans.
Product Composition
- Active Ingredient: Ondansetron (as hydrochloride dihydrate).
- Formulation: Oral tablets (Available in 4mg and 8mg strengths).
- Key Characteristic: Rapidly acting; prevents nausea rather than just treating it after onset.
Product Specification
| Feature | Details |
| Therapeutic Class | Antiemetic / Antinauseant |
| Primary Indication | Prevention of chemotherapy/radiotherapy-induced nausea and vomiting (CINV/RINV) |
| Secondary Indication | Prevention and treatment of post-operative nausea and vomiting (PONV) |
| Administration | Oral |
| Storage | Store below 30°C in a dry place; protect from light |
Mechanism of Action
- Serotonin Blockade: Ondansetron works by competitively blocking 5-$HT_3$ receptors located both peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the brain.
- Inhibition of Vomiting Reflex: By inhibiting serotonin binding at these sites, the medication interrupts the signaling pathway that triggers the vomiting reflex in response to cytotoxic agents or surgical stress.
- Targeted Effect: Unlike older antiemetics, ondansetron is highly selective for 5-$HT_3$ receptors, resulting in fewer sedative and extrapyramidal side effects.
Key Benefits
- High Efficacy: Established as a gold-standard therapy for managing nausea associated with highly emetogenic cancer treatments.
- Prophylactic Use: Ideally taken before the onset of symptoms, making it an essential component of treatment protocols for patients undergoing chemotherapy or surgery.
- Improved Patient Quality of Life: By mitigating the distressing symptoms of nausea and vomiting, it allows patients to maintain better nutritional intake and overall wellbeing during demanding medical therapies.
- Oral Convenience: Tablets offer an easy-to-administer format for outpatient management of nausea.
- Favorable Safety Profile: Generally well-tolerated with a low incidence of adverse effects compared to non-selective agents.
Precautions
Important precautions for Emeset Tablets (Ondansetron)
Heart and cardiac precautions
- May affect heart rhythm (QT prolongation) in some patients
- Use cautiously in patients with heart disease or electrolyte imbalance
- Report palpitations, dizziness, or fainting immediately
- Regular monitoring may be required in high-risk individuals
Electrolyte and dehydration precautions
- Correct dehydration before use if possible
- Low potassium or magnesium levels may increase risk of side effects
- Maintain proper fluid balance during treatment
- Monitor electrolytes in repeated or high-dose use
Liver function precautions
- Use cautiously in patients with liver impairment
- Dose adjustment may be required in severe liver disease
- Monitor liver function in prolonged therapy
- Report yellowing of skin or persistent fatigue
Neurological precautions
- May cause headache or dizziness
- Use caution when driving or operating machinery
- Avoid alcohol as it may worsen dizziness
- Observe for unusual restlessness or confusion
General usage precautions
- Take exactly as prescribed without exceeding dose
- Not intended for long-term self-medication
- Inform doctor about all ongoing medications
- Use with caution in elderly patients
Safety overview table
| Area of caution | Precaution guidance |
|---|---|
| Heart health | Risk of QT prolongation, monitor rhythm |
| Electrolytes | Correct imbalance before use |
| Liver function | Dose adjustment may be required |
| Nervous system | May cause dizziness or headache |
Usage
Dosage
Dosage is highly specific to the indication and the patient's individual treatment plan. Doses should be timed precisely in relation to medical procedures to ensure maximum prophylactic effect.
| Indication | Typical Dosage |
| Chemotherapy-Induced Nausea | 8 mg taken 30 minutes before the start of chemotherapy |
| Radiation-Induced Nausea | 8 mg taken 1–2 hours before radiation therapy |
| Post-Operative Nausea | 8 mg taken one hour before the induction of anesthesia |
Administration
Prophylactic Timing: Emeset is most effective when taken before the onset of nausea. Adhere strictly to the schedule provided by your oncologist or surgical team.
Consistency: Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet.
With or Without Food: Can be taken regardless of meals. If taking for post-operative care, follow any specific fasting instructions provided by your hospital.
Follow-up Dosing: Depending on the treatment protocol, your physician may instruct you to take additional doses at specific intervals (e.g., every 8–12 hours) after your initial treatment.
Missed Dose: If you miss a scheduled dose, take it as soon as you remember. If it is nearly time for your next dose, skip the missed dose and resume your regular schedule. Do not take a double dose.
Storage: Keep tablets in their original packaging at room temperature, away from moisture and direct heat.
Uses
Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV): Used to prevent acute and delayed nausea and vomiting associated with both highly and moderately emetogenic cancer chemotherapy regimens.
Prevention of Radiotherapy-Induced Nausea and Vomiting (RINV): Indicated for patients receiving total body irradiation or radiation therapy to the abdomen or thorax.
Prevention and Treatment of Post-Operative Nausea and Vomiting (PONV): Utilized to prevent the distress and complications associated with nausea following surgical procedures under general or regional anesthesia.
Support for Nutritional Intake: By effectively controlling nausea, the medication enables patients to maintain adequate oral intake of food and fluids during aggressive medical therapies.
Adherence to Treatment Protocols: Facilitates patient compliance with essential cancer or surgical treatments by mitigating the most frequent and distressing side effects of those therapies.
Side effects
Common side effects
- Headache
- Dizziness
- Constipation
- Fatigue or tiredness
Gastrointestinal effects
- Mild abdominal discomfort
- Dry mouth
- Bloating or indigestion
- Rare nausea (paradoxical)
Nervous system effects
- Drowsiness
- Lightheadedness
- Blurred vision (rare)
- Restlessness in some cases
Cardiac effects (rare but important)
- Irregular heartbeat (QT prolongation)
- Palpitations
- Fainting or severe dizziness
- Changes in blood pressure
Allergic reactions (rare)
- Skin rash or itching
- Swelling of face, lips, or throat
- Severe hypersensitivity reactions
- Breathing difficulty (requires urgent care)
Side effects summary table
| System affected | Possible reaction |
|---|---|
| Nervous system | Headache, dizziness, drowsiness |
| Gastrointestinal | Constipation, dry mouth, discomfort |
| Cardiovascular | QT prolongation, palpitations |
| General | Fatigue, tiredness |
| Allergic reactions | Rash, swelling, breathing difficulty |
FAQs
Q: What is Emeset used for?
A: Emeset (ondansetron) is used to prevent and treat nausea and vomiting associated with cancer chemotherapy, radiation therapy, and surgical procedures (post-operative).
Q: How does Emeset differ from other anti-nausea medicines?
A: It is a selective 5-$HT_3$ receptor antagonist. This means it specifically targets the serotonin receptors that trigger the vomiting center in the brain and gut, often providing more effective relief with fewer sedative side effects than older antiemetic medications.
Q: When should I take the tablet?
A: For chemotherapy or radiation, it is typically taken shortly before your treatment begins. For post-operative nausea, it is usually taken as directed by your surgical team, either before or shortly after your procedure.
Q: Can I take it with food?
A: Yes, you can take Emeset with or without food. If you find that it upsets your stomach, taking it with a small snack may help.
Q: What should I do if I vomit after taking a dose?
A: If you vomit shortly after taking a tablet, contact your doctor to see if you should take another dose. Do not take an extra dose without consulting a healthcare professional first.
Q: What are the common side effects?
A: The most common side effects include headache, constipation, fatigue, or a warm/flushing sensation. These are usually mild and manageable.
Q: Does it cause drowsiness?
A: Unlike many other anti-nausea medications, Emeset is not typically associated with significant sedation. However, if you feel unusually tired, avoid driving or operating machinery until you know how it affects you.
Q: Can I take this for general nausea (like a stomach bug or motion sickness)?
A: Emeset is specifically designed for nausea triggered by chemotherapy, radiation, or surgery. It is generally not the first-line treatment for common viral stomach bugs or motion sickness; please consult your doctor for the appropriate treatment for those conditions.
Interactions
Drug interactions of Emeset Tablets (Ondansetron)
Heart rhythm medicines
- Drugs that prolong QT interval may increase risk of serious arrhythmias
- Antiarrhythmic medicines may enhance cardiac side effects
- Combination requires ECG monitoring in high-risk patients
Serotonergic medicines
- SSRIs and SNRIs may slightly increase risk of serotonin syndrome
- MAO inhibitors and other serotonergic drugs require caution
- Monitor for symptoms like agitation, sweating, or confusion
Pain and anesthesia medicines
- Tramadol may have reduced pain control effectiveness
- Opioid medicines may increase risk of constipation and sedation
- Used commonly with antiemetic support in surgery settings
Liver enzyme affecting medicines
- CYP3A4 inducers may reduce effectiveness of Ondansetron
- CYP inhibitors may increase drug levels and side effects
- Dose adjustments may be needed in interacting therapies
General medication considerations
- Antacids and common gastrointestinal medicines usually have minimal interaction
- Alcohol may worsen dizziness and side effects
- Always inform doctor about all prescription and OTC medicines
Drug interactions table
| Drug class | Interaction effect |
|---|---|
| QT-prolonging drugs | Increased risk of serious heart rhythm disturbances |
| SSRIs/SNRIs/MAOIs | Possible serotonin syndrome risk |
| CYP3A4 inducers | Reduced effectiveness of Ondansetron |
| CYP3A4 inhibitors | Increased drug levels and side effects |
| Tramadol | Reduced analgesic effectiveness |
| Manufacturer | : | Cipla Pharma, India |
| Trade Name | : | Zofran |
| Generic Search | : | Ondansetron |
| Strength | : | 4mg, 8mg |
Latest Products
